Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 11676 [2015-04469]

Download as PDF mstockstill on DSK4VPTVN1PROD with NOTICES 11676 Federal Register / Vol. 80, No. 42 / Wednesday, March 4, 2015 / Notices announces the following meeting of the aforementioned committee: Times and Dates: 10:00 a.m.–5:00 p.m., EDT, March 25, 2015 8:00 a.m.–3:30 p.m., EDT, March 26, 2015 Place: Centers for Disease Control and Prevention (CDC), Global Communications Center, Building 19, Auditorium B3, 1600 Clifton Road NE., Atlanta, Georgia 30333 Status: Open to the public limited only by the space available. The meeting room will accommodate up to 90 people. Public participants should preregister for the meeting as described in Additional Information for Public Participants. Members of the public that wish to attend this meeting should preregister by submitting the following information by email, facsimile, or phone (see Contact Person for More Information) no later than 12:00 noon (EDT) on Tuesday, March 17, 2015: • Full Name • Organizational Affiliation • Complete Mailing Address • Citizenship • Phone Number or Email Address Purpose: This Board is charged with providing advice and guidance to the Secretary, Department of Health and Human Services (HHS), the Assistant Secretary for Health (ASH), the Director, Centers for Disease Control and Prevention (CDC), and the Director, Office of Public Health Preparedness and Response (OPHPR), concerning strategies and goals for the programs and research within OPHPR, monitoring the overall strategic direction and focus of the OPHPR Divisions and Offices, and administration and oversight of peer review of OPHPR scientific programs. For additional information about the Board, please visit: https:// www.cdc.gov/phpr/science/ counselors.htm. Matters for Discussion: Day one of the meeting will cover briefings and BSC deliberation on the following topics: Interval updates from OPHPR Divisions and Offices; key issues associated with CDC’s response to the Ebola outbreak; mental and behavioral health and emergency preparedness and response; and BSC liaison representative updates to the Board highlighting organizational activities relevant to the OPHPR mission. Day two of the meeting will cover briefings and BSC deliberation on the following topics: Hurricane Sandy Recovery Research Initiative overview; select agent regulations; National Health Security Preparedness Index Update; and OPHPR impact measurement. VerDate Sep<11>2014 18:11 Mar 03, 2015 Jkt 235001 Agenda items are subject to change as priorities dictate. Contact Person for More Information: Sparkle Buissereth, Executive Assistant, Office of Science and Public Health Practice, Centers for Disease Control and Prevention, 1600 Clifton Road NE., Mailstop D–44, Atlanta, Georgia 30333, Telephone: (404) 639–7325; Facsimile: (404) 639–7977; Email: OPHPR.BSC.Questions@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention, and Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–04466 Filed 3–3–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Public Health Research on Modifiable Risk Factors for Spina Bifida, DD15–001, initial review. This document corrects a notice that was published in the Federal Register on February 18, 2015 Volume 80, Number 32, pages 8661. The time and date should read as follows: Time And Date: 11:00 a.m.–6:00 p.m., March 19, 2015 (Closed). SUMMARY: FOR FURTHER INFORMATION CONTACT: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F46, Atlanta, Georgia 30341, Telephone: (770) 488– 3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and PO 00000 Frm 00048 Fmt 4703 Sfmt 9990 Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–04469 Filed 3–3–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to DP15–006, Investigating New Approaches for Tobacco Surveillance Systems. Time and Date: 11:00 a.m.–6:30 p.m., March 24, 2015 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Investigating New Approaches for Tobacco Surveillance Systems’’, DP15– 006. Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–04411 Filed 3–3–15; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\04MRN1.SGM 04MRN1

Agencies

[Federal Register Volume 80, Number 42 (Wednesday, March 4, 2015)]
[Notices]
[Page 11676]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-04469]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Public Health Research on 
Modifiable Risk Factors for Spina Bifida, DD15-001, initial review.

SUMMARY: This document corrects a notice that was published in the 
Federal Register on February 18, 2015 Volume 80, Number 32, pages 8661. 
The time and date should read as follows:
    Time And Date: 11:00 a.m.-6:00 p.m., March 19, 2015 (Closed).

FOR FURTHER INFORMATION CONTACT: M. Chris Langub, Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway NE., Mailstop F46, Atlanta, 
Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-04469 Filed 3-3-15; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.